← Back to Search

Fatherhood Engagement Program for Substance Use Disorders

N/A
Recruiting
Led By Scott Wetzler, PhD
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up follow up (6-months after baseline)
Awards & highlights
No Placebo-Only Group

Summary

This trial will help Bronx families at risk of substance misuse get enhanced services, incl. motivational enhancement, a fatherhood program, & case management.

Who is the study for?
This trial is for fathers, whether they live with their children or not, who have at least one child under 18. They must be part of a family where someone is at risk for substance use issues. Fathers whose children are all in foster care cannot participate.
What is being tested?
The study tests if extra support services can help fathers in families at risk of substance misuse. Some dads will get usual services; others will also get motivational talks, the HERO Dads program, rewards for positive behavior (Contingency Management), and Case Management.
What are the potential side effects?
Since this trial involves behavioral interventions rather than medications, traditional side effects like those seen with drugs are not expected. However, participants may experience emotional discomfort or stress due to the sensitive nature of the topics discussed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~follow up (6-months after baseline)
This trial's timeline: 3 weeks for screening, Varies for treatment, and follow up (6-months after baseline) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Child well-being, as measured by: Child Behavior Checklist

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Enhanced Fatherhood Services through Regional Partnership Grant Round 7 (RPG7)Experimental Treatment4 Interventions
Randomly assigned to receive enhanced RPG7 services (motivational enhancement, fatherhood engagement services, contingency management, case management)
Group II: Services as UsualActive Control1 Intervention
Randomly assigned to receive services as usual
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Case Management
2012
Completed Phase 2
~3370
Contingency Management
2014
Completed Phase 4
~3440
Motivational Enhancement
1999
Completed Phase 3
~3150

Find a Location

Who is running the clinical trial?

Montefiore Medical CenterLead Sponsor
458 Previous Clinical Trials
588,374 Total Patients Enrolled
Albert Einstein College of MedicineOTHER
296 Previous Clinical Trials
11,689,213 Total Patients Enrolled
Scott Wetzler, PhDPrincipal InvestigatorMontefiore Medical Center
3 Previous Clinical Trials
3,976 Total Patients Enrolled

Media Library

HERO Dads Fatherhood Program Clinical Trial Eligibility Overview. Trial Name: NCT05562557 — N/A
Child Abuse Research Study Groups: Services as Usual, Enhanced Fatherhood Services through Regional Partnership Grant Round 7 (RPG7)
Child Abuse Clinical Trial 2023: HERO Dads Fatherhood Program Highlights & Side Effects. Trial Name: NCT05562557 — N/A
HERO Dads Fatherhood Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05562557 — N/A
~152 spots leftby Sep 2027